 Natalie Davidson
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystadenocarcinoma, Serous | 2 | 2025 | 69 | 1.080 |
Why?
| | Software | 2 | 2025 | 608 | 1.050 |
Why?
| | Single-Cell Analysis | 3 | 2025 | 277 | 1.020 |
Why?
| | Ovarian Neoplasms | 3 | 2025 | 490 | 0.930 |
Why?
| | Journalism | 1 | 2024 | 7 | 0.900 |
Why?
| | Computational Biology | 2 | 2025 | 599 | 0.720 |
Why?
| | Computer Graphics | 1 | 2017 | 41 | 0.540 |
Why?
| | Algorithms | 2 | 2025 | 1622 | 0.460 |
Why?
| | Internet | 1 | 2017 | 616 | 0.400 |
Why?
| | Computer Simulation | 2 | 2025 | 943 | 0.270 |
Why?
| | Neoplasm Grading | 2 | 2025 | 285 | 0.270 |
Why?
| | Genomics | 3 | 2025 | 716 | 0.230 |
Why?
| | Authorship | 1 | 2024 | 45 | 0.220 |
Why?
| | Bibliometrics | 1 | 2024 | 54 | 0.220 |
Why?
| | Sexism | 1 | 2024 | 55 | 0.210 |
Why?
| | Science | 1 | 2024 | 49 | 0.210 |
Why?
| | Glycine Hydroxymethyltransferase | 1 | 2022 | 16 | 0.200 |
Why?
| | Biomarkers, Tumor | 2 | 2025 | 1181 | 0.180 |
Why?
| | Periodicals as Topic | 1 | 2024 | 204 | 0.180 |
Why?
| | Interleukin-2 | 1 | 2022 | 436 | 0.180 |
Why?
| | Metabolomics | 1 | 2024 | 652 | 0.160 |
Why?
| | Eukaryotic Initiation Factor-1 | 1 | 2018 | 2 | 0.150 |
Why?
| | Activating Transcription Factor 4 | 1 | 2018 | 20 | 0.150 |
Why?
| | Sex Factors | 1 | 2024 | 1968 | 0.150 |
Why?
| | Proteomics | 1 | 2024 | 1062 | 0.140 |
Why?
| | ras Proteins | 1 | 2018 | 144 | 0.140 |
Why?
| | Sulfobromophthalein | 1 | 2017 | 1 | 0.140 |
Why?
| | Carcinogenesis | 1 | 2018 | 213 | 0.130 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2020 | 1356 | 0.130 |
Why?
| | Alternative Splicing | 1 | 2018 | 218 | 0.130 |
Why?
| | Systems Biology | 1 | 2017 | 59 | 0.130 |
Why?
| | Female | 7 | 2025 | 68770 | 0.130 |
Why?
| | Jews | 1 | 2016 | 19 | 0.130 |
Why?
| | Humans | 12 | 2025 | 129622 | 0.130 |
Why?
| | Pharmaceutical Preparations | 1 | 2017 | 171 | 0.120 |
Why?
| | Genetics, Population | 1 | 2016 | 200 | 0.120 |
Why?
| | Thyroid Neoplasms | 1 | 2018 | 310 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2022 | 882 | 0.120 |
Why?
| | Linear Models | 1 | 2017 | 819 | 0.110 |
Why?
| | Mice | 4 | 2025 | 16937 | 0.110 |
Why?
| | RNA | 1 | 2020 | 883 | 0.110 |
Why?
| | Mutation | 2 | 2025 | 3717 | 0.100 |
Why?
| | Animals | 4 | 2025 | 35360 | 0.080 |
Why?
| | Signal Transduction | 1 | 2022 | 4925 | 0.080 |
Why?
| | Male | 3 | 2025 | 63674 | 0.080 |
Why?
| | Aged | 2 | 2025 | 22099 | 0.080 |
Why?
| | Liver | 1 | 2017 | 1839 | 0.070 |
Why?
| | Middle Aged | 2 | 2025 | 31150 | 0.070 |
Why?
| | Transcriptome | 2 | 2024 | 887 | 0.060 |
Why?
| | Neoplasms | 1 | 2020 | 2470 | 0.060 |
Why?
| | Peptide Elongation Factor 2 | 1 | 2022 | 4 | 0.050 |
Why?
| | Dactinomycin | 1 | 2022 | 28 | 0.050 |
Why?
| | Cycloheximide | 1 | 2022 | 56 | 0.050 |
Why?
| | Peptide Elongation Factors | 1 | 2022 | 15 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 429 | 0.050 |
Why?
| | RNA Splice Sites | 1 | 2022 | 44 | 0.050 |
Why?
| | 5' Untranslated Regions | 1 | 2022 | 55 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 52 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2022 | 72 | 0.050 |
Why?
| | Serine | 1 | 2022 | 138 | 0.050 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 634 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 274 | 0.040 |
Why?
| | Immunologic Memory | 1 | 2022 | 349 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2022 | 332 | 0.040 |
Why?
| | DNA, Neoplasm | 1 | 2020 | 159 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2020 | 170 | 0.040 |
Why?
| | Pyrimidines | 1 | 2022 | 459 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2022 | 1106 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1706 | 0.040 |
Why?
| | Mice, SCID | 1 | 2018 | 351 | 0.040 |
Why?
| | Genome, Human | 1 | 2020 | 393 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2018 | 588 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 940 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2022 | 857 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 2018 | 406 | 0.030 |
Why?
| | Israel | 1 | 2016 | 47 | 0.030 |
Why?
| | Pakistan | 1 | 2016 | 75 | 0.030 |
Why?
| | India | 1 | 2016 | 170 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2018 | 814 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2018 | 396 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 257 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1084 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2022 | 2708 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2022 | 3215 | 0.030 |
Why?
| | Haplotypes | 1 | 2016 | 475 | 0.030 |
Why?
| | Phosphorylation | 1 | 2018 | 1713 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2025 | 7084 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 891 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2391 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1839 | 0.020 |
Why?
| | Apoptosis | 1 | 2018 | 2503 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2016 | 1333 | 0.020 |
Why?
| | Adult | 1 | 2025 | 35572 | 0.010 |
Why?
|
|
Davidson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|